ABIOMED Inc. (ABMD)
Symbol Info
Listed Symbol ABMD
Name ABIOMED Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2019-03-31
Latest Fiscal Revenue $769,432,000
Latest Fiscal EPS $5.61
Price Info
21 Day Moving Average $176.9238
21 Day EMA $174.447850
50 Day Moving Average $185.6948
50 Day EMA $191.524290
200 Day EMA $251.217420
200 Day Moving Average 266.565700
52 Week High $427.70
52 Week Low $155.02
52 Week Change $-53.844498
Alpha 0.032809
Beta 0.3541
Standard Deviation 0.123441
R2 0.009716
Periods 60
Share Information
10 Day Average Volume 712,825
20 Day Average Volume 645,112
30 Day Average Volume 588,554
50 Day Average Volume 619,217
Outstanding Shares 45,376,713
Float Shares 42,443,639
Percent Float 93.54%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 1,220
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 7,709,627
Institute Holdings Percent -
Institute Sold Previous 3 Months 6,475,301
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months 18
Insider Holdings Percent 6.50%
Insider Sold Previous 3 Months -
Insiders Shares Owned 2,933,074
Price Change
7 Day Price Change $0.3899994
7 Day Percent Change 0.23%
21 Day Price Change $-23.119995
21 Day Percent Change -11.99%
30 Day Price Change $-21.430008
30 Day Percent Change -11.22%
Month To Date Price Change $-8.25
Month To Date Percent -4.64%
90 Day Price Change $-96.45
90 Day Percent Change -36.25%
Quarter To Date $-8.25
Quarter To Date Percent -4.64%
180 Day Price Change $-102.250015
180 Day Percent Change -37.61%
200 Day Price Change $-143.58
200 Day Percent Change -45.84%
Year To Date $-155.40001
Year To Date Percent -47.81%
Profile
Description Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are primarily used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. They work by improving blood flow to coronary arteries or temporarily performing the pumping function of the heart. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.
Details
Issue Type CS
Market Cap $7,697,705,593
Sec Type EQS
Auditor Deloitte & Touche LLP
Total Shares Outstanding 45,376,713
CEO Michael R. Minogue
Employees 1,371
Last Audit UE
Classification
CIK 0000815094
Industry Medical Devices
Sector Healthcare
NAICS Surgical and Medical Instrument Manufacturing(339112)
Info
Address 22 Cherry Hill Drive
Danvers, MA 1923
Website http://www.abiomed.com
Facisimile +1 978 777-8411
Telephone +1 978 646-1400
Email mediarelations@abiomed.com
Key Ratios
Profitability
EBIT Margin 30.00
EBITDA Margin 31.9
Pre-Tax Profit Margin 22.8
Profit Margin Cont 33.76
Gross Margin 83.00
Profit Margin TOT 33.76
Income Statements
Revenue $615,310,000
Revenue Per Share $13.5600
Revenue 3 Years $21.63
Revenue 5 Years $30.17
Valuation Measures
PE Ratio 29.20
Enterprise Value $7,585,391,475
Price To Sales 12.510288
Price To Free Cash 41.000000
PE High Last 5 Years 393.2
Price To Book 7.4
Price To Cash Flow 27.9
PE Low Last 5 Years 22.3
Price To Tangible Book 7.8
Financial Strength
Total Debt To Equity -
Int Coverage -
Current Ratio 6.8
Leverage Ratio 1.1
Quick Ratio 5.7
Long Term Debt To Capital -
Assets
Receivables Turnover 3.4
Invoice Turnover 1.80
Assets Turnover 0.30
Management Effectiveness
Return Assets 26.62
Return On Equity 29.88
Return On Capital 29.88
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
ABMD
ABIOMED
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.